COLUMN GROUP II, LP - 12 Nov 2021 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Reporting relationship: 10%+ Owner
Issuer ticker: ORIC
Reported as of: 12 Nov 2021
Net transaction value: +$266,000
SEC form: 4
Accepted by SEC: 16 Nov 2021, 15:49:13 UTC
Prior SEC filing: 29 Sep 2021
Next SEC filing: 12 May 2022
Source filing: View source filing
Reporting owner signature: /s/ James Evangelista, as Attorney-in-fact for David Goeddel

Key filing fact

COLUMN GROUP II, LP filed Form 4 for Oric Pharmaceuticals, Inc. (ORIC) on 16 Nov 2021.

Key facts

This page summarizes COLUMN GROUP II, LP's Form 4 filing for Oric Pharmaceuticals, Inc. (ORIC).
8 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Nov 2021, 15:49.

Change

Previous filing in this sequence was filed on 29 Sep 2021.
Current net transaction value: +$266,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ORIC transaction

Common Stock

Options Exercise

Transaction value: $266,000
Shares: +16,625
Change %
Price: $16.00
Shares after: 16,625
Date: 12 Nov 2021
Ownership: See Footnote
Footnotes: F1

ORIC transaction

Common Stock

Other

Transaction value: $0
Shares: -1,200,000
Change %: -25%
Price: $0.000000
Shares after: 3,568,181
Date: 16 Nov 2021
Ownership: Direct
Footnotes: F2, F3

ORIC transaction

Common Stock

Other

Transaction value: $0
Shares: +287,702
Change %
Price: $0.000000
Shares after: 287,702
Date: 16 Nov 2021
Ownership: See Footnote
Footnotes: F4, F5

ORIC transaction

Common Stock

Other

Transaction value: $0
Shares: -287,702
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 16 Nov 2021
Ownership: See Footnote
Footnotes: F5, F6

ORIC transaction

Common Stock

Other

Transaction value: $0
Shares: +86,716
Change %
Price: $0.000000
Shares after: 86,716
Date: 16 Nov 2021
Ownership: See Footnote
Footnotes: F7, F8

ORIC transaction

Common Stock

Other

Transaction value: $0
Shares: +86,716
Change %: +522%
Price: $0.000000
Shares after: 103,341
Date: 16 Nov 2021
Ownership: See Footnote
Footnotes: F1, F9

ORIC transaction

Common Stock

Other

Transaction value: $0
Shares: +74
Change %
Price: $0.000000
Shares after: 74
Date: 16 Nov 2021
Ownership: See Footnote
Footnotes: F10, F11

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ORIC transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -16,625
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 12 Nov 2021
Ownership: See Footnote
Underlying class: Common Stock
Underlying amount: 16,625
Exercise price: $16.00
Footnotes: F1, F12, F13

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 13 footnotes

Footnote F1

These securities are directly held by Peter Svennilson. Peter Svennilson is a former member of the Issuer's board of directors and previously filed his own Section 16 reports reporting his holdings.

Footnote F2

Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by The Column Group II, LP ("TCG II LP") to its general and limited partners.

Footnote F3

The securities are directly held by TCG II LP, and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson (collectively, the "TCG II GP Managing Partners"). The TCG II GP Managing Partners may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual TCG II GP Managing Partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Footnote F4

Represents a change in the form of ownership of TCG II GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by TCG II LP.

Footnote F5

The securities are directly held by TCG II GP. The TCG II GP Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG II GP and each individual TCG II GP Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Footnote F6

Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by TCG II GP to its partners.

Footnote F7

Represents a change in the form of ownership of David Goeddel by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by TCG II GP.

Footnote F8

These securities are directly held by David Goeddel.

Footnote F9

Represents a change in the form of ownership of Peter Svennilson by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by TCG II GP.

Footnote F10

Represents a change in the form of ownership of The Column Group, LLC ("TCG LLC") by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by TCG II GP.

Footnote F11

These securities are directly held by TCG LLC. The managing members of TCG LLC are the TCG II GP Managing Partners and Timothy Kutzkey (collectively, the "TCG LLC Managing Partners"). The TCG LLC Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG LLC and each of the TCG LLC Managing Partners disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Footnote F12

As of the transaction date, 16,625 of the shares subject to this option have vested.

Footnote F13

The option was granted to Peter Svennilson for his service as a member of the Issuer's board of directors.